Astria Therapeutics, Inc. - ATXS Net Assets per Single Share

Graphic logo of Astria Therapeutics (ATXS)

Astria Therapeutics (ATXS) business is burdened by colossal R&D costs, meaning profit growth remains limited until marketing authorizations for its drugs are obtained, with the indicator standing at 2.46. The team consists of top immunologists attracted by competitive compensation and modern perks. This price chart reflects the dynamics of a company fighting for patent superiority and the safety of its molecules during FDA reviews.

Astria Therapeutics Inc (ATXS): Share Book Value from 07/04/2022 to 02/07/2026

astriatx.com - analytical breakdowns and key metrics (ATXS)

- price and consensus price forecast:
Stock Quotes Astria Pharma|ATXS - Broker Consensus Forecast
- market capitalization data:
Market Value Astria Therapeutics, Inc.|ATXS - Company Buyout Price
- book capitalization data:
Net Assets per Single Share Astria Therapeutics|ATXS - Net Asset Value|Market Capitalization to Book Value Ratio astriatx.com|ATXS - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Astria Therapeutics|ATXS - Long-Term Debt to Capital|Short-Term Debt to Equity Astria Therapeutics, Inc.|ATXS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Astria Therapeutics, Inc.
Fundamental company valuation:Astria Pharma - ATXS
Manufactured products of Astria Therapeutics, Inc.

Book value per share reflects the net value of the company's assets minus all liabilities, allowing investors to assess the actual internal capital of the firm regardless of market speculation. The book value trend for Astria Therapeutics (ATXS) demonstrates the financial foundation for developing innovative antibodies against angioedema, confirming the biopharmaceutical business's ability to sustain long-term R&D projects using its own reserves.

Competitors of Astria Therapeutics (ATXS)

Argenx (ARGX) - Accounting Value per Share|BNTX: Equity per Share|Abivax Corp - Net Assets per Single Share|ADMA (admabiologics.com) - Net Assets per Share|Net Assets per Single Share Protagonist PTGX|Share Book Value Immunovant Inc|Kiniksa Pharmaceuticals Ltd (KNSA) - Book Value per Share|Accounting Value of a Share Grifols Biemat (GRFS)|Book Value per Share ADPT (Adaptive Biotechnologies)|celldex.com - Book Value per Share|Net Assets per Single Share Aurinia Pharmaceuticals Inc. (AUPH)|BCRX: Accounting Value of a Share|VERA (Vera Pharma) - Net Assets per Single Share|Dianthus Corp (DNTH) - Accounting Value per Share|PHVS (Pharvaris N.V.) - Book Value per Share|Book Value per Share AbCellera Corp (ABCL)|Tourmaline Bio (TRML) - Accounting Value per Share|Accounting Value of a Share Precigen Inc (PGEN)|Book Value per Share PHAR|Nektar Corp - Net Assets per Share|UPB: Net Assets per Single Share|ZBIO: Accounting Value per Share|IMNM (Immunome) - Net Assets per Single Share|Accounting Value per Share Gossamer Bio Inc|KALV (KalVista Pharmaceuticals Inc) - Accounting Value per Share|Book Value per Share SEPN|Net Assets per Single Share Pieris Pharmaceuticals PVLA|Equity per Share savarapharma.com (SVRA)|RIGL: Book Value per Share|Net Asset Value per Share AnaptysBio Inc ANAB|enGene Bio - Book Value per Share|RAPT: Book Value per Share|aerovatetx.com - Net Assets per Single Share|Net Assets per Share aclaristx.com|Kyverna Therapeutics, Inc. (KYTX) - Accounting Value per Share|Book Price of a Share TLSA|Cabaletta Bio, Inc (CABA) - Net Assets per Single Share|Accounting Value of a Share Ventyx Biosciences, Inc (VTYX)|Book Value per Share THTX|Net Assets per Share avalotx.com AVTX|Eledon Pharmaceuticals, Inc. - Book Value per Share|Agenus, Inc. (AGEN) - Book Value per Share|Accounting Value per Share Climb Bio, Inc. CLYM|Accounting Value of a Share Zura Bio Ltd|aTyr Pharma, Inc. (ATYR) - Accounting Value per Share|Book Price of a Share Adagene Corp|ImageneBio Inc (IMA) - Book Value per Share|Accounting Value of a Share shattucklabs.com (STTK)|EQ: Book Value per Share|Connect Biopharma Holdings - Net Asset Value per Share|Net Assets per Single Share Immunic Inc (IMUX)|ATRA - Accounting Value of a Share|IFRX: Book Value per Share|XFOR (X4 Pharmaceuticals Inc.) - Book Value per Share|Net Assets per Single Share Adicet Bio Inc. ACET|Share Book Value Celularity Corp|INmune Bio, Inc. - Book Value per Share|Net Asset Value per Share barinthusbio.com BRNS|Accounting Value per Share KZR (Kezar Life Sciences, Inc.)|SABS - Book Value per Share|Accounting Value per Share Akari Therapeutics plc AKTX|ENLV - Book Price of a Share|q32bio.com - Book Value per Share|geovax.com (GOVX) - Net Assets per Share|Book Value per Share EDSA|Accounting Value per Share IBIO|CARM (Carisma Therapeutics) - Net Assets per Single Share|Net Assets per Share XTL Bio (XTLB)|Book Value per Share BOLT (Bolt Biotherapeutics, Inc.)|HCWB - Book Value per Share|Accounting Value per Share Aptevo APVO|AIM ImmunoTech, Inc. (AIM) - Book Price of a Share|Accounting Value per Share aditxt.com|GRI (GRI Bio Corporation) - Equity per Share|XRTX: Net Assets per Single Share|Net Assets per Share HIND|REVB - Net Assets per Single Share|Share Book Value Indaptus Therapeutics Inc (INDP)|Book Value per Share Scinai|Accounting Value of a Share CalciMedica Inc CALI|Affimed Therapeutics - Book Value per Share|ALLK: Book Value per Share|Net Assets per Single Share hookipapharma.com HOOK|IGMS (IGM Biosciences) - Accounting Value of a Share|Net Assets per Single Share ITOS|Accounting Value per Share Ocean Biomedical Corp|Book Value per Share TCBP|Book Value per Share thirdharmonicbio.com THRD